TRV GP IV, LLC
- SEC CIK
- 0001688325
- Latest filing
- Aug 7, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 13, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 3
- 0 vs. Q2 2023
- Portfolio value
- $265.4M
- +$154.8M (+139.8%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TNGXTango Therapeutics, Inc. | COM | 19,363,975 | $218.0M | 82.1% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,132,867 | $37.0M | 13.9% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 2,343,154 | $10.4M | 3.9% | 00.0% | Unchanged | History |